Curs 2020-2021ancer is a complex disease caused by the abnormal behavior and interaction of different bio entities (e.g., genes, proteins and epigenetic factors), which are profiled using omics technologies (e.g., transcriptomics, proteomics and epigenomics). Traditionally, each omic have been analyzed individually through different methods, however, the major source of the cancer complexity lies on that interaction among the elements involved. Amongst the most common computational techniques in this field, machine learning, a branch of artificial intelligence that builds data-driven models, is the key due to its capacity to transform biological data into knowledge. Ensemble machine learning and deep learning, two areas which ar...
Artificial intelligence-based unsupervised deep learning (DL) is widely used to mine multimodal big ...
Cancer is a concerning disease for many people nowadays because of its high mortality rate and its h...
Microsatellite instability (MSI) has been approved as a pan-cancer biomarker for immune checkpoint b...
Please refer to the readme in the github link https://github.com/zhenglinyi/DL-mo. for the specific ...
MOTIVATION: Recent advances in multimodal single-cell omics technologies enable multiple modalities ...
Identification and prediction of cancer subtypes are important parts in the development towards pers...
In recent years, high-throughput sequencing technologies provide unprecedented opportunity to depict...
Summary: Cancer is an extremely complex disease and each type of cancer usually has several differen...
© 2020 Richard LupatRapid advancement in genomic technologies has driven down the cost of sequencing...
Comprehensive molecular characterization of cancer subtypes is essential for predicting clinical out...
The rise of machine learning (ML) has recently buttressed the efforts for big data-driven precision ...
Cancer subtyping (or cancer subtypes identification) based on multi-omics data has played an importa...
Abstract Background One approach to improving the personalized treatment of cancer is to understand ...
BackgroundComprehensive molecular profiling has revealed somatic variations in cancer at genomic, ep...
High-dimensional omics data contain intrinsic biomedical information that is crucial for personalise...
Artificial intelligence-based unsupervised deep learning (DL) is widely used to mine multimodal big ...
Cancer is a concerning disease for many people nowadays because of its high mortality rate and its h...
Microsatellite instability (MSI) has been approved as a pan-cancer biomarker for immune checkpoint b...
Please refer to the readme in the github link https://github.com/zhenglinyi/DL-mo. for the specific ...
MOTIVATION: Recent advances in multimodal single-cell omics technologies enable multiple modalities ...
Identification and prediction of cancer subtypes are important parts in the development towards pers...
In recent years, high-throughput sequencing technologies provide unprecedented opportunity to depict...
Summary: Cancer is an extremely complex disease and each type of cancer usually has several differen...
© 2020 Richard LupatRapid advancement in genomic technologies has driven down the cost of sequencing...
Comprehensive molecular characterization of cancer subtypes is essential for predicting clinical out...
The rise of machine learning (ML) has recently buttressed the efforts for big data-driven precision ...
Cancer subtyping (or cancer subtypes identification) based on multi-omics data has played an importa...
Abstract Background One approach to improving the personalized treatment of cancer is to understand ...
BackgroundComprehensive molecular profiling has revealed somatic variations in cancer at genomic, ep...
High-dimensional omics data contain intrinsic biomedical information that is crucial for personalise...
Artificial intelligence-based unsupervised deep learning (DL) is widely used to mine multimodal big ...
Cancer is a concerning disease for many people nowadays because of its high mortality rate and its h...
Microsatellite instability (MSI) has been approved as a pan-cancer biomarker for immune checkpoint b...